Research Library
-
Published Study Reviews
AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits
-
Evidence & Quality Guides
AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity
-
Published Study Reviews
CJC-1295 With DAC in Healthy Adults: GH, IGF-1 and Half-Life Data
-
Evidence & Quality Guides
CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context
-
Published Study Reviews
CJC-1295 Without DAC: Why the Classic Long-Acting Trial Does Not Apply
-
Evidence & Quality Guides
CJC-1295 Without DAC: Sequence, Naming and a Quality Checklist
-
Published Study Reviews
Survodutide in SYNCHRONIZE-1: The 2026 Phase 3 Numbers in Context
-
Evidence & Quality Guides
Survodutide Research Status: Dual Glucagon/GLP-1 Biology, Trials and Material Identity
-
Published Study Reviews
Elamipretide in Barth Syndrome: What the 12-Patient Trial and FDA Record Show
-
Evidence & Quality Guides
SS-31, Elamipretide and Forzinity: Why the Finished-Drug Distinction Matters
-
Published Study Reviews
Ibutamoren (MK-677) in Older Adults: Two-Year Body-Composition Data and the Missing Functional Gain
-
Evidence & Quality Guides
MK-677 / Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions